Advanced Biohealing Inc, a regenerative drug maker, said it would price its initial public offering at $14-$16 per share and expects to raise about $200 million.

Of the total 13.4 million shares, the company will sell 8.4 million, while the rest will be offered by selling stockholders, it said in a regulatory filing.

The Westport, Connecticut-based company posted revenue of $146.7 million in 2010, up almost 72 percent from the prior year. Advanced BioHealing plans to list on the New York Stock Exchange under the symbol "ABHB".